Back to results
Completed

An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment

NCT00696995

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novo Nordisk Investigational Site

Lahti, Finland

View on ClinicalTrials.gov
An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment — TrialFind